Glipizide osmotic pump controlled release tablet
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- HEFEI HUAFANG PHARMA SCI & TECH
- Publication Date
- 2015-03-18
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention relates to the field of pharmaceutical preparations, in particular to an osmotic pump controlled-release tablet containing the active drug glipizide and a preparation method thereof. The controlled-release tablet can make the drug enter the gastrointestinal tract at a constant rate, so that the drug with low solubility Glipizide is released at a constant rate. Background technique
[0002] Glipizide (Glipizide, chemical name: 5-methyl-N-[2-[4-[[[(cyclohexylamino)carbonyl]amino]sulfonphthalein]phenyl]ethyl]-pyrazinecarboxamide ), a second-generation sulfonylurea oral hypoglycemic drug, mainly used for the treatment of patients with mild to moderate non-insulin-dependent diabetes mellitus. In vivo and in vitro experiments have shown that the main mechanism of action of glipizide is to stimulate the β cells of the pancreas to secrete insulin, enhance the effect of insulin on the target tissue, and also stimulate the α cells of the pancreas ...